Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Virulizin: IMUTF next month will begin a 20-patient Phase I/II dose escalation study of Virulizin</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

The bovine bile extract stimulates macrophages. ......

cancer

Gastrointestinal

Virulizin: IMUTF next month will begin a 20-patient Phase I/II dose escalation study of Virulizin

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

BioCentury-BayHelix East-West Summit 2027

East-West Biopharma Summit

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home